Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026)
Arcus Biosciences' (RCUS) quarterly Interest & Investment Income came in at $9.0 million in Q1 2026, down 18.18% year-on-year from $11.0 million in Q1 2025, and down 10.0% quarter-over-quarter from $10.0 million in Q4 2025.
Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026) Analysis & Trends
Arcus Biosciences' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $9.0 million for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 18.18% year-over-year to $9.0 million in Q1 2026; TTM through Mar 2026 was $39.0 million, a 22.0% decrease from a year earlier, with the FY2025 full-year figure at $41.0 million, down 21.15% from the prior year.
- Interest & Investment Income retreated to $9.0 million in Q1 2026 per RCUS's latest filing, from $10.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $14.0 million in Q3 2024 and bottomed at $582000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $10.0 million (2025), against an average of $9.4 million.
- Across the five-year window, Interest & Investment Income surged 3005.59% in 2022 and fell 28.57% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $8.0 million in 2022, then surged by 37.5% to $11.0 million in 2023, then rose by 9.09% to $12.0 million in 2024, then retreated by 16.67% to $10.0 million in 2025, then fell by 10.0% to $9.0 million in 2026.
- Per Business Quant, the three latest RCUS Interest & Investment Income figures stand at $9.0 million (Q1 2026), $10.0 million (Q4 2025), and $10.0 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Arcus Biosciences | 3.57 Bn | 2.75 Bn | - | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | 10.00 Mn |
| Sep 30, 2025 | 10.00 Mn |
| Jun 30, 2025 | 10.00 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 12.00 Mn |
| Sep 30, 2024 | 14.00 Mn |
| Jun 30, 2024 | 13.00 Mn |
| Mar 31, 2024 | 13.00 Mn |
| Dec 31, 2023 | 11.00 Mn |
| Sep 30, 2023 | 12.00 Mn |
| Jun 30, 2023 | 9.00 Mn |
| Mar 31, 2023 | 9.00 Mn |
| Dec 31, 2022 | 8.00 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 3.00 Mn |
| Mar 31, 2022 | 582,000.00 |
| Dec 31, 2021 | 519,000.00 |
| Sep 30, 2021 | 161,000.00 |
| Jun 30, 2021 | 166,000.00 |